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Preoperative evaluation, including blood testing, is 
an integral part of providing safe perioperative care. [1] 
However, routine preoperative blood testing is no 
longer advocated, as several studies have highlighted 
the absence of negative outcomes associated with the 
omission of investigations and the low frequency of abnormal results 
in healthy patients undergoing low-risk surgery.[2,3] Blood tests should 
therefore only be conducted when specifically indicated. In many 
centres, local guidelines have been developed to assist doctors in 
performing appropriate preoperative investigations.
In addition, inappropriate preoperative blood testing is costly.[4,5] 
This is of particular importance in a highly cost-conscious environment 
such as the South African (SA) health sector. As stated by the National 
Treasury in 2013: ‘… departments and spending agencies do have 
to learn to do more with less. In the period ahead, improvements 
in outcomes have to come from qualitative improvements in the 
use of available budgets and other inputs.’[6] The concept of ‘cost-
consciousness’ among doctors needs to become a more pertinent 
aspect of daily practice.
Objective
To determine the appropriateness of preoperative blood testing, and 
possible cost implications, in adult patients booked for orthopaedic, 
general or trauma surgical procedures at a regional hospital in 
KwaZulu-Natal Province, SA.
Methods
We conducted a retrospective observational study approved by 
the hospital manager, KwaZulu-Natal Department of Health, and 
the University of KwaZulu-Natal Biomedical Research Ethics 
Committee (Ref: BE345/14). A systematic convenience sampling 
method was used and data were collected retrospectively from 
eligible charts on an alternate week (Monday to Sunday) cycle over 
8 weeks. This provided a total of 4 weeks of data collection over 2 
consecutive months. Only routine clinical data from eligible charts 
were used. All adult patients (≥18 years of age) undergoing elective 
or non-elective surgery in the disciplines of general, trauma or 
orthopaedic surgery were included. Patients requiring surgery 
while admitted to the intensive care, high-care and burn units 
were excluded, as were those who had undergone high-risk surgery 
within the last 6 months. Surgical risk was classified as low or high 
using previously published criteria.[7]
The primary study endpoint was the incidence of inappropri-
ate preoperative blood tests across a range of laboratory tests. 
Those evaluated were full blood count (FBC), urea, creatinine and 
electrolytes (UE), liver function testing (LFT), the international 
normalised ratio (INR), blood gas analyses (ABG), calcium, magne-
sium and phosphate (CMP), C-reactive protein (CRP), erythrocyte 
sedimentation rate (ESR) and albumin. Results were expressed as a 
percentage of inappropriate tests against the total number of tests 
performed. The appropriateness of a blood test was determined by 
the Pietermaritzburg Metropolitan Department of Anaesthesia’s 
guidelines on preoperative blood testing for elective and non-elective 
surgery (Appendix 1). Where the appropriateness of preoperative 
blood testing could not be ascertained clearly, the relevant data were 
reviewed separately by DB and RR, both anaesthetic consultants 
familiar with the departmental protocol.
The cost implication of unnecessary preoperative blood testing was 
determined by multiplying the cost of the relevant blood test by the 
number of unnecessary respective tests performed in the sample. The 
cost of the relevant blood tests was obtained from the National Health 
Laboratory Service (NHLS) 2014 State Pricing List.
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Results
Cohort characteristics
A total of 320 eligible patient charts were 
reviewed, and the charac teristics of the cohort 
are summarised in Table 1. The majority of 
surgical procedures at the study hospital 
are done on low-risk patients (81.9%), 
patients who are ≤60 years of age (84.4%) 
and those who have an American Society 
of Anesthesiologists (ASA) physical status 
grading of 1 or 2 (86.9%). Comorbidities 
observed included asthma, diabetes, vascular 
disease, hypertension, epilepsy and HIV 
infection. The charts reflected 131 (40.9%) 
general surgical, 15 (4.7%) trauma and 174 
(54.4%) orthopaedic surgery cases.
Preoperative testing practices
New preoperative blood testing was 
performed either on admission or 
before surgery on all but two of the 320 
patients evaluated. Only one patient had 
no preoperative testing performed, and 
one patient had results from the referral 
hospital with no subsequent testing. Eight 
of the included patients had more than one 
surgical procedure, with no repeat testing 
between procedures. The most commonly 
performed preoperative blood tests were 
an FBC (310) and UE (310). Additional 
frequently performed tests included LFT, 
INR, ABG, CMP, CRP, ESR and albumin. 
Observed preoperative testing practices are 
summarised in Table 2.
Inappropriate tests included 190 FBCs 
(61.3%), 206 UEs (66.4%), 92 LFTs (97.9%) 
and 49 INRs (92.5%). The majority of 
patients who received inappropriate tests 
were <45 years of age, graded as ASA 1, or 
undergoing a low-risk surgical procedure. 
In addition, we noted that four patients 
were discharged after surgery without their 
blood results being documented in their 
files. Further, in 60 charts the FBC and 
UE were repeated perioperatively without 
any clear indication, and in seven charts 
admission blood tests were performed twice 
within 24 hours. With no clearly delineated 
surgical, trauma or orthopaedic preoperative 
guidelines, it was not possible to determine 
the appropriateness of blood testing for 
surgical purposes relative to anaesthetic 
indications.
The documentation of blood results on 
anaesthetic forms was also reviewed. No 
blood results were documented on 11.9% of 
charts, 24.0% of charts had documented ward 
haemoglobin only, and 1.6% had a blood gas 
result only. Adequate documentation for 
appropriate FBCs and UEs was observed 
in 70.0% and 67.3% of charts, respectively. 
Despite the high prevalence of unnecessary 
blood testing, there was also inadequate 
documentation of appropriate tests on the 
anaesthetic charts.
Cost implications
The total cost of the inappropriate tests 
performed was ZAR72 375. The largest 
contributors to this included 92 LFTs 
(ZAR29 349), 206 UEs (ZAR15 817) and 
the combined group of CMP, albumin, 
ESR and CRP (ZAR12 566). The cost of 
repeat and duplicate testing practices that 
were observed was ZAR8 643. In total, the 
estimated cost of unnecessary perioperative 
testing in a 4-week period was ZAR81 018.
Discussion 
This study demonstrates that inappropriate 
blood testing is common in patients 
booked for both elective and non-elective 
orthopaedic, trauma or general surgical 
procedures – this despite the existence of 
locally developed anaesthetic preoperative 
testing guidelines. The majority of 
procedures that take place at the study 
hospital involve low-risk surgery in patients 
<60 years of age and with an ASA grading 
of 1 or 2. These patient groups undergo 
unnecessary testing that has significant cost 
implications.
The role of preoperative blood testing is 
to assist in the detection of abnormalities 
that could alter patient management and 
lead to better outcomes. In a recent study, 
Benarroch-Gampel et al.[3] examined 
patterns of preoperative blood testing in 
73 596 patients undergoing elective hernia 
repair, of whom 46 977 underwent testing. 
Tests included FBC, creatinine, electrolytes, 
LFT and coagulation parameters. Their 
findings suggested that a large proportion 
of testing for low-risk ambulatory surgery, 
even in patients with stable comorbid illness, 
is of questionable clinical benefit and can 
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Age group (years) n (%) ASA grading n (%)
<45 45 - 60 >61 1 and 2 3 4
FBC 310 253 (81.6) 195 (62.9) 67 (21.6) 48 (15.5) 270 (87.1) 37 (11.9) 3 (1.0)
UE 310 253 (81.6) 194 (62.9) 67 (21.6) 49 (15.8) 269 (86.8) 38 (12.3) 3 (1.0)
LFT 94 65 (69.1) 54 (57.4) 21 (22.3) 19 (20.2) 75 (79.8) 17 (18.1) 2 (2.1)
CMP 81 65 (80.2) 41 (50.6) 20 (24.7) 20 (24.7) 62 (76.5) 18 (22.2) 1 (1.2)
CRP 55 44 (80.0) 38 (69.1) 10 (18.2) 7 (12.7) 49 (89.1) 6 (10.9) -
ABG 54 35 (64.8) 33 (61.1) 14 (25.9) 7 (13.0) 43 (79.6) 9 (16.7) 2 (3.7)
INR 53 43 (81.1) 27 (50.9) 15 (28.3) 11 (20.8) 39 (73.6) 12 (22.6) 2 (3.8)
ESR 41 32 (78.0) 29 (70.7) 7 (17.1) 5 (12.2) 38 (92.7) 3 (7.3) -
Albumin 35 28 (80.0) 15 (42.9) 12 (34.3) 8 (22.9) 28 (80.0) 6 (17.1) 1 (2.9)
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be eliminated without significant adverse 
medical consequences. 
Surgical indications for specific tests must 
also be addressed, e.g. LFTs, albumin, ESR, 
CRP and CMP. Their place in perioperative 
care needs to be challenged, especially in 
young, healthy patients undergoing low-risk 
surgery.
Lilford et al.[8] reviewed a cohort of 1 290 
patients with abnormal LFT results. They 
concluded that LFT was associated with a 
high false-positive rate and often performed 
for reasons other than that of clinical 
indication. They advocate a more selective 
approach to LFT instead of screening all 
liver enzymes.
Albumin is a controversial biomarker of 
nutritional status, as many other factors, 
including inflammation, metabolic stress, 
trauma and dehydration, can affect serum 
levels.[9] Studies suggest that it can be used as 
a prognostic marker to identify those at risk 
of complications following surgery and poor 
postoperative outcome.[9] However, this is 
not applicable in patients undergoing low-
risk surgery.
Both the ESR and CRP are nonspecific 
tests that reflect inflammation associated 
with infection or autoimmune disease. CRP 
in particular can be used as a monitor for 
postoperative infection and could assist in 
identifying patients who are developing 
severe sepsis.[10] However, once again their 
indication in the healthy patient undergoing 
low-risk surgery must be questioned.
Disorders in mineral metabolism are 
complex. Multiple organ systems, in particular 
the bone mineral content, neurological and 
cardiovascular systems, can be affected by 
altered levels of calcium, magnesium and 
phosphate.[11] Critical illness can have various 
effects on CMP levels, for multiple reasons. 
This would justify regular CMP monitoring 
in critical illness. However, CMP testing in 
the majority of patients is of questionable 
value without clear clinical indications.
Numerous international studies have 
highlighted the cost implications of 
inappropriate blood testing.[4,5] It must 
also be emphasised that testing not only 
has financial implications but means 
unnecessary discomfort to patients, 
increased occupational exposure to the risk 
of needlestick injuries, and time lost through 
acquiring blood samples, waiting for results 
and addressing false-positive tests.
Perioperative care should be a multi-
disciplinary process involving both the 
surgeon and the anaesthetist. Addressing 
unnecessary preoperative blood testing 
practices should not be the sole responsibility 
of the surgeon or the anaesthetist, but 
rather a process of information sharing and 
resource management. This study highlights 
that inappropriate preoperative blood testing 
is evident despite available anaesthetic 
guidelines.
Reasons for non-compliance were 
not explored in this study. However, a 
qualitative study by Brown and Brown[12] 
identified various factors responsible 
for unnecessary testing despite available 
guidelines. These included: (i) lack of 
awareness of guidelines; (ii) medicolegal 
concerns; (iii) concern about surgical 
delays or cancellations; and (iv) the belief 
that other physicians may require the 
test results. Surgeons and anaesthetists 
need to collaborate to ensure knowledge 
translation and together address 
implementation issues around current 
preoperative testing guidelines.
Administrative interventions must also be 
instituted.[13] The NHLS has implemented 
some of these through electronic 
gatekeeping, limiting volumes and type of 
tests ordered, but this tool is not yet available 
at all state hospitals.[14] Further examples of 
such interventions include: (i) modification 
of laboratory request forms to limit available 
options; (ii) imposing a specific time 
interval on subsequent testing to prevent 
repeat testing; (iii) restricting the ordering of 
specific tests to consultant request only; and 
(iv) encouraging a selective testing approach, 
as summarised in Table 3.
Finally, the current literature on 
preoperative testing is based on US, 
Canadian or European population groups. 
The SA population has lower socioeconomic 
living conditions than those in the northern 
hemisphere, and disease profiles differ. 
There is no literature validating preoperative 
testing guidelines appropriate to the SA 
population at present, and future studies are 
required. Reasons behind local preoperative 
blood testing practices and non-compliance 
with guidelines also need to be explored and 
addressed.
Study limitations
Given that this was a retrospective study, all 
study data were limited by the subjectivity 
of the attending doctor’s assessment of the 
clinical condition of the patient and the 
ASA grading. Furthermore, at the time of 
the study, no clearly delineated surgical 
or orthopaedic guidelines were available 
regarding preoperative investigations 
required.
Conclusion
This study demonstrates that inappropriate 
blood testing often occurs in patients 
booked for elective and non-elective 
general, orthopaedic and trauma surgical 
procedures, and that it was common in the 
younger patient, ASA 1 or 2 and low-risk 
surgery groups. Mis- and overutilisation 
of blood testing has a significant impact 
on healthcare costs. SA doctors need to 
become more cost-conscious in their 
approach to laboratory testing practices in 
preoperative patients.
Table 3. Options available for a selective testing approach
Test required Test options Cost implications
Hb FBC ZAR52.23
FBC and differential ZAR80.87 (ZAR52.23 + ZAR28.64)
Hb only ZAR16.24
Hb POCT* Unknown: cost-effective[15]
Albumin Albumin only ZAR36.23











Hb = haemoglobin; POCT = point-of-care testing.
*Hb POCT together with clinical findings. 
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